002793 罗欣药业
已收盘 11-06 15:00:00
资讯
新帖
简况
罗欣药业（002793）披露转让控股子公司股权进展公告，11月05日股价上涨1.96%
证券之星 · 11-05 22:34
罗欣药业（002793）披露转让控股子公司股权进展公告，11月05日股价上涨1.96%
罗欣药业：对方反馈其与赛隆药业本次合作的业务渠道和我司原有独家授权渠道并不相同
证券之星 · 11-05 15:07
罗欣药业：对方反馈其与赛隆药业本次合作的业务渠道和我司原有独家授权渠道并不相同
罗欣药业：控股股东质押股份不存在平仓风险
证券之星 · 11-05 15:07
罗欣药业：控股股东质押股份不存在平仓风险
股市必读：罗欣药业新发布《关于控股股东部分股份补充质押的公告》
证券之星 · 11-04 03:20
股市必读：罗欣药业新发布《关于控股股东部分股份补充质押的公告》
罗欣药业（002793）股东山东罗欣控股有限公司质押500万股，占总股本0.46%
证券之星 · 11-03
罗欣药业（002793）股东山东罗欣控股有限公司质押500万股，占总股本0.46%
股市必读：罗欣药业三季报 - 第三季度单季净利润同比增长120.21%
证券之星 · 10-28
股市必读：罗欣药业三季报 - 第三季度单季净利润同比增长120.21%
罗欣药业(002793)9月30日股东户数4.16万户，较上期减少4.23%
证券之星 · 10-27
罗欣药业(002793)9月30日股东户数4.16万户，较上期减少4.23%
罗欣药业（002793）10月27日主力资金净买入112.00万元
证券之星 · 10-27
罗欣药业（002793）10月27日主力资金净买入112.00万元
图解罗欣药业三季报：第三季度单季净利润同比增长120.21%
证券之星 · 10-27
图解罗欣药业三季报：第三季度单季净利润同比增长120.21%
股市必读：罗欣药业（002793）10月22日收盘跌5%，主力净流出361万元
证券之星 · 10-23
股市必读：罗欣药业（002793）10月22日收盘跌5%，主力净流出361万元
罗欣药业：截至目前股东尚未收到执行法院出具的股权处置安排通知
证券之星 · 10-22
罗欣药业：截至目前股东尚未收到执行法院出具的股权处置安排通知
股市必读：罗欣药业（002793）10月14日董秘有最新回复
证券之星 · 10-15
股市必读：罗欣药业（002793）10月14日董秘有最新回复
罗欣药业：该1,000万元借款发生于四川罗欣纳入公司合并报表期间
证券之星 · 10-14
罗欣药业：该1,000万元借款发生于四川罗欣纳入公司合并报表期间
罗欣药业（002793）披露为控股子公司提供担保的进展公告，10月09日股价上涨3.16%
证券之星 · 10-09
罗欣药业（002793）披露为控股子公司提供担保的进展公告，10月09日股价上涨3.16%
股市必读：罗欣药业新发布《第六届董事会第十次会议决议公告》
证券之星 · 10-08
股市必读：罗欣药业新发布《第六届董事会第十次会议决议公告》
罗欣药业（002793）9月28日主力资金净买入502.75万元
证券之星 · 09-28
罗欣药业（002793）9月28日主力资金净买入502.75万元
股市必读：罗欣药业新发布《关于为控股子公司提供担保的进展公告》
证券之星 · 09-28
股市必读：罗欣药业新发布《关于为控股子公司提供担保的进展公告》
罗欣药业：注射用LX22001已完成II期临床并达到主要研究终点
证券之星 · 09-21
罗欣药业：注射用LX22001已完成II期临床并达到主要研究终点
股市必读：罗欣药业（002793）9月9日董秘有最新回复
证券之星 · 09-10
股市必读：罗欣药业（002793）9月9日董秘有最新回复
罗欣药业：2026年上半年营业收入同比增长6.52%
证券之星 · 09-09
罗欣药业：2026年上半年营业收入同比增长6.52%
加载更多
公司概况
公司名称：
罗欣药业集团股份有限公司
所属行业：
医药制造业
上市日期：
2016-04-15
主营业务：
罗欣药业集团股份有限公司的主营业务是药品制剂（含检测服务）及原料药的研发、生产和商业化。公司的主要产品是泰欣赞（替戈拉生片）。
发行价格：
11.97
{"stockData":{"symbol":"002793","market":"SZ","secType":"STK","nameCN":"罗欣药业","latestPrice":4.09,"timestamp":1793948622000,"preClose":4.16,"halted":0,"volume":13012600,"delay":0,"changeRate":-0.0168,"floatShares":1086000000,"shares":1088000000,"eps":-0.23,"marketStatus":"已收盘","change":-0.07,"latestTime":"11-06 15:00:00","open":4.06,"high":4.15,"low":4.02,"amount":53223600,"amplitude":0.0313,"askPrice":4.09,"askSize":2518,"bidPrice":4.08,"bidSize":2573,"shortable":0,"etf":0,"ttmEps":-0.23,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794187800000},"marketStatusCode":5,"adr":0,"adjPreClose":4.16,"symbolType":"stock","openAndCloseTimeList":[[1793928600000,1793935800000],[1793941200000,1793948400000]],"highLimit":4.58,"lowLimit":3.74,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1087588486,"isCdr":false,"pbRate":3.94,"roa":"--","roe":"5.48%","epsLYR":-0.2718,"committee":0.291649,"marketValue":4448000000,"turnoverRate":0.012,"status":1,"floatMarketCap":4441000000},"requestUrl":"/m/hq/s/002793","defaultTab":"news","newsList":[{"id":"2681710750","title":"罗欣药业（002793）披露转让控股子公司股权进展公告，11月05日股价上涨1.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2681710750","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681710750?lang=zh_cn&edition=full","pubTime":"2026-11-05 22:34","pubTimestamp":1793889261,"startTime":"0","endTime":"0","summary":"截至2026年11月5日收盘，罗欣药业报收于4.16元，较前一交易日上涨1.96%，最新总市值为45.24亿元。该股当日开盘4.09元，最高4.18元，最低4.06元，成交额达6695.07万元，换手率为1.49%。罗欣药业于近日披露《关于转让控股子公司股权的进展公告》。公告显示，公司于2026年9月29日召开董事会，审议通过转让控股子公司罗欣药业（安徽）有限公司51%股权的议案。山东罗欣将其持有的安徽罗欣51%股权以1,947万元价格转让给合肥罗鑫医药科技有限公司。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110500043238.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002793","BK0132","BK0001","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681604315","title":"罗欣药业：对方反馈其与赛隆药业本次合作的业务渠道和我司原有独家授权渠道并不相同","url":"https://stock-news.laohu8.com/highlight/detail?id=2681604315","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681604315?lang=zh_cn&edition=full","pubTime":"2026-11-05 15:07","pubTimestamp":1793862435,"startTime":"0","endTime":"0","summary":"近期未知君官宣与赛隆药业达成深度战略合作，同步开展全国FMT业务拓展，与公司原有独家合作赛道、业务场景高度重合：公司至今未发布任何进展公告、风险公告、合作变更或边界说明公告，请问是否涉嫌信息披露不及时、不完整及违规？经公司与未知君核实，对方反馈其与赛隆药业本次合作的业务渠道和我司原有独家授权渠道并不相同，不属于协议约定的排他范围，不存在侵害公司独家经销权益的情形。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110500022366.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0132","BK0201","002793","BK0001"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681043166","title":"罗欣药业：控股股东质押股份不存在平仓风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2681043166","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681043166?lang=zh_cn&edition=full","pubTime":"2026-11-05 15:07","pubTimestamp":1793862434,"startTime":"0","endTime":"0","summary":"控股股东及一致行动人未来一年内到期的质押股份对应融资余额为5,500万元，其资信状况良好，具备相应的资金偿还能力，将根据自身经营资金安排、债务到期计划筹措资金，保障按期履约。目前控股股东质押股份不存在平仓风险或被强制过户风险，同时公司已建立关联交易、对外担保等内控管控机制，做好风险防控。公司将持续跟踪控股股东质押及债务情况，若后续事项达到信息披露标准，将及时履行披露义务，敬请投资者注意风险。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110500022365.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0001","BK0132","BK0201","002793","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680715977","title":"股市必读：罗欣药业新发布《关于控股股东部分股份补充质押的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2680715977","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680715977?lang=zh_cn&edition=full","pubTime":"2026-11-04 03:20","pubTimestamp":1793733622,"startTime":"0","endTime":"0","summary":"截至2026年11月3日收盘，罗欣药业报收于3.99元，下跌1.72%，换手率1.44%，成交量15.67万手，成交额6303.74万元。公司公告汇总关于控股股东部分股份补充质押的公告罗欣药业集团股份有限公司接到控股股东山东罗欣控股有限公司通知，其持有的5,000,000股公司股份被补充质押，占其所持股份比例2.11%，占公司总股本比例0.46%，质权人为安徽国元信托有限责任公司，质押用途为补充质押。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400004526.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0201","BK0001","002793","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680764811","title":"罗欣药业（002793）股东山东罗欣控股有限公司质押500万股，占总股本0.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680764811","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680764811?lang=zh_cn&edition=full","pubTime":"2026-11-03 01:16","pubTimestamp":1793639798,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业11月3日公开信息显示，股东山东罗欣控股有限公司向安徽国元信托有限责任公司合计质押500.0万股，占总股本0.46%。质押详情见下表：截止本公告日，股东山东罗欣控股有限公司已累计质押股份1.41亿股，占其持股总数的59.63%。罗欣药业主营业务：药品制剂及原料药的研发、生产和商业化。本文数据来源于罗欣药业公告，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110300002781.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0001","BK0132","BK0239","002793"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678489179","title":"股市必读：罗欣药业三季报 - 第三季度单季净利润同比增长120.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678489179","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678489179?lang=zh_cn&edition=full","pubTime":"2026-10-28 05:09","pubTimestamp":1793135371,"startTime":"0","endTime":"0","summary":"截至2026年10月27日收盘，罗欣药业报收于4.01元，下跌6.09%，换手率2.72%，成交量29.52万手，成交额1.21亿元。交易信息汇总股价提醒10月27日罗欣药业收盘报4.01元，跌6.09%，当日成交1.21亿元。其中第三季度单季度主营收入5.32亿元，同比下降17.64%；单季度归母净利润1152.08万元，同比上升120.21%；单季度扣非净利润578.61万元，同比上升121.05%；负债率66.6%，投资收益620.1万元，财务费用3270.71万元，毛利率57.99%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800006517.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002793"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678175133","title":"罗欣药业(002793)9月30日股东户数4.16万户，较上期减少4.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678175133","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678175133?lang=zh_cn&edition=full","pubTime":"2026-10-27 18:46","pubTimestamp":1793097977,"startTime":"0","endTime":"0","summary":"证券之星消息，近日罗欣药业披露，截至2026年9月30日公司股东户数为4.16万户，较8月20日减少1837.0户，减幅为4.23%。在化学制药行业个股中，罗欣药业股东户数高于行业平均水平，截至9月30日，化学制药行业平均股东户数为3.84万户。从股价来看，2026年8月20日至2026年9月30日，罗欣药业区间跌幅为9.23%，在此期间股东户数减少1837.0户，减幅为4.23%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700035033.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0001","BK0239","BK0132","002793","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678125192","title":"罗欣药业（002793）10月27日主力资金净买入112.00万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2678125192","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678125192?lang=zh_cn&edition=full","pubTime":"2026-10-27 15:37","pubTimestamp":1793086639,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月27日收盘，罗欣药业报收于4.01元，下跌6.09%，换手率2.72%，成交量29.52万手，成交额1.21亿元。10月27日的资金流向数据方面，主力资金净流入112.0万元，占总成交额0.93%，游资资金净流入1011.59万元，占总成交额8.39%，散户资金净流出1123.59万元，占总成交额9.32%。罗欣药业主营业务：药品制剂及原料药的研发、生产和商业化。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700024448.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0001","BK0132","BK0239","002793"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678113525","title":"图解罗欣药业三季报：第三季度单季净利润同比增长120.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678113525","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678113525?lang=zh_cn&edition=full","pubTime":"2026-10-27 02:15","pubTimestamp":1793038504,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业2026年三季报显示，前三季度公司主营收入16.8亿元，同比下降2.54%；归母净利润6145.49万元，同比上升168.05%；扣非净利润3615.48万元，同比上升635.12%；其中2026年第三季度，公司单季度主营收入5.32亿元，同比下降17.64%；单季度归母净利润1152.08万元，同比上升120.21%；单季度扣非净利润578.61万元，同比上升121.05%；负债率66.6%，投资收益620.1万元，财务费用3270.71万元，毛利率57.99%。财报数据概要请见下图:本文数据来源于罗欣药业2026年三季报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700003363.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002793"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677995504","title":"股市必读：罗欣药业（002793）10月22日收盘跌5%，主力净流出361万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677995504","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677995504?lang=zh_cn&edition=full","pubTime":"2026-10-23 03:25","pubTimestamp":1792697158,"startTime":"0","endTime":"0","summary":"截至2026年10月22日收盘，罗欣药业报收于4.18元，下跌5.0%，换手率1.96%，成交量21.24万手，成交额9039.16万元。交易信息汇总股价提醒10月22日罗欣药业收盘报4.18元，跌5%，当日成交9039.16万元。前10个交易日资金流向情况：主力资金累计净流出5156.75万元，股价累计下跌5%。资金流向10月22日主力资金净流出361.0万元，占总成交额3.99%；游资资金净流入478.46万元，占总成交额5.29%；散户资金净流出117.47万元，占总成交额1.3%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300004046.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0001","BK0132","BK0239","002793"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677987291","title":"罗欣药业：截至目前股东尚未收到执行法院出具的股权处置安排通知","url":"https://stock-news.laohu8.com/highlight/detail?id=2677987291","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677987291?lang=zh_cn&edition=full","pubTime":"2026-10-22 11:33","pubTimestamp":1792640006,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业10月22日在投资者关系平台上答复投资者关心的问题。本次股权冻结系公司股东自身涉诉事项，属于股东层面事务，公司在持续向股东跟进核实相关进展。经与股东沟通核实，截至目前，股东尚未收到执行法院出具的股权处置安排通知。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102200016145.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0239","BK0001","BK0201","002793"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675329291","title":"股市必读：罗欣药业（002793）10月14日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2675329291","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675329291?lang=zh_cn&edition=full","pubTime":"2026-10-15 01:49","pubTimestamp":1792000151,"startTime":"0","endTime":"0","summary":"截至2026年10月14日收盘，罗欣药业报收于4.68元，下跌2.5%，换手率1.46%，成交量15.86万手，成交额7474.77万元。董秘最新回复投资者： 请问截止2026年10月10日公司的股东人数是多少？根据相关规则要求，公司股东人数将在定期报告中进行披露，敬请关注公司后续相关公告。当日关注点交易信息汇总：10月14日主力资金净流出682.51万元，占总成交额9.13%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500001643.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0239","002793","BK0001","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675969563","title":"罗欣药业：该1,000万元借款发生于四川罗欣纳入公司合并报表期间","url":"https://stock-news.laohu8.com/highlight/detail?id=2675969563","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675969563?lang=zh_cn&edition=full","pubTime":"2026-10-14 08:46","pubTimestamp":1791938769,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业10月13日在投资者关系平台上答复投资者关心的问题。该1,000万元借款发生于四川罗欣纳入公司合并报表期间，系山东罗欣为支持其业务发展提供的资金支持，该笔借款与本次股权转让相互独立。根据借款协议约定，上述借款若发生逾期，公司将收取逾期资金占用费并加收利息，以此约束对方按期履约、保障上市公司资金安全；四川罗欣法定代表人王绍雄就该笔借款向山东罗欣提供无条件、不可撤销的连带责任保证。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400007421.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0201","002793","BK0132","BK0001"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674302958","title":"罗欣药业（002793）披露为控股子公司提供担保的进展公告，10月09日股价上涨3.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674302958","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674302958?lang=zh_cn&edition=full","pubTime":"2026-10-09 17:39","pubTimestamp":1791538756,"startTime":"0","endTime":"0","summary":"截至2026年10月9日收盘，罗欣药业报收于4.89元，较前一交易日上涨3.16%，最新总市值为53.18亿元。罗欣药业集团股份有限公司于近日披露《关于为控股子公司提供担保的进展公告》。公告显示，公司为控股子公司罗欣药业（上海）有限公司向招商银行申请的1,000万元流动资金贷款提供连带责任保证担保，同时公司向上海市中小微企业政策性融资担保基金管理中心提供反担保。公司及控股子公司对外担保总余额为116,098.06万元，占最近一期经审计净资产的99.74%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900027834.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0201","BK0001","BK0239","002793"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673101417","title":"股市必读：罗欣药业新发布《第六届董事会第十次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2673101417","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673101417?lang=zh_cn&edition=full","pubTime":"2026-10-08 01:20","pubTimestamp":1791393622,"startTime":"0","endTime":"0","summary":"公司公告汇总第六届董事会第十次会议决议公告2026年9月29日，罗欣药业召开第六届董事会第十次会议，审议通过关于2024年员工持股计划部分离职人员未解锁股票转让给高级管理人员的议案，将合计31.005万份权益收回，并分别转让给总经理陈明和财务负责人武永生；同时审议通过转让控股子公司安徽罗欣51%股权和四川罗欣51%股权的议案，转让后该两家子公司不再纳入合并报表范围。相关议案均获全票通过。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800000827.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0001","BK0239","BK0201","002793","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670828522","title":"罗欣药业（002793）9月28日主力资金净买入502.75万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2670828522","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670828522?lang=zh_cn&edition=full","pubTime":"2026-09-28 15:29","pubTimestamp":1790580568,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月28日收盘，罗欣药业报收于4.75元，上涨1.93%，换手率2.68%，成交量29.06万手，成交额1.38亿元。9月28日的资金流向数据方面，主力资金净流入502.75万元，占总成交额3.65%，游资资金净流入919.08万元，占总成交额6.67%，散户资金净流出1421.83万元，占总成交额10.32%。罗欣药业主营业务：医药产品的研发、生产和销售。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800014601.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0132","BK0001","BK0239","002793"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670409486","title":"股市必读：罗欣药业新发布《关于为控股子公司提供担保的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2670409486","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670409486?lang=zh_cn&edition=full","pubTime":"2026-09-28 02:01","pubTimestamp":1790532073,"startTime":"0","endTime":"0","summary":"公司公告汇总：公司为控股子公司山东罗欣新增5,000万元担保，担保余额升至112,023.71万元，对外担保总额占最近一期经审计净资产的99.43%。山东罗欣为公司持股99.65%的控股子公司，非失信被执行人，经营正常，资信良好。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800001080.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0001","BK0132","BK0201","002793"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669375153","title":"罗欣药业：注射用LX22001已完成II期临床并达到主要研究终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2669375153","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669375153?lang=zh_cn&edition=full","pubTime":"2026-09-21 15:07","pubTimestamp":1789974444,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业09月21日在投资者关系平台上答复投资者关心的问题。LX22001 二期完成后迟迟不启动 III 期，核心障碍是临床数据不理想还是资金不足？注射用LX22001已完成II期临床并达到主要研究终点，公司正在综合评估临床数据、市场环境、资源配置，并非受资金不足影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100013484.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0001","BK0132","BK0239","002793"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666325705","title":"股市必读：罗欣药业（002793）9月9日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2666325705","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666325705?lang=zh_cn&edition=full","pubTime":"2026-09-10 01:40","pubTimestamp":1788975623,"startTime":"0","endTime":"0","summary":"截至2026年9月9日收盘，罗欣药业报收于4.74元，下跌1.66%，换手率1.8%，成交量19.58万手，成交额9288.33万元。董秘最新回复投资者： 请问董秘，公司定增预案一年了为什么仍未有资金到位？交易信息汇总资金流向9月9日主力资金净流出8.83万元，占总成交额0.1%；游资资金净流出206.28万元，占总成交额2.22%；散户资金净流入215.11万元，占总成交额2.32%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000002103.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","002793","BK0201","BK0001","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666832435","title":"罗欣药业：2026年上半年营业收入同比增长6.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666832435","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666832435?lang=zh_cn&edition=full","pubTime":"2026-09-09 15:57","pubTimestamp":1788940625,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业09月09日在投资者关系平台上答复投资者关心的问题。2026年上半年，公司营业收入同比增长6.52%，不存在销售收入下降的情形。本期市场推广费占营业收入的比例为26.06%，2025年上半年及2025年全年该比例分别为22.61%和27.71%，公司市场推广投入总体处于与业务发展相匹配的水平。从经营结果看，2026年上半年P-CAB产品销量同比增长超过30%，市场覆盖和产品渗透持续提升。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090900023860.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002793"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793966330568,"stockEarnings":[{"period":"1week","weight":0.0426},{"period":"1month","weight":-0.1369},{"period":"3month","weight":-0.2195},{"period":"6month","weight":-0.2409},{"period":"1year","weight":-0.2353},{"period":"ytd","weight":-0.1333}],"compareEarnings":[{"period":"1week","weight":0.0105},{"period":"1month","weight":-0.0396},{"period":"3month","weight":-0.0635},{"period":"6month","weight":-0.1172},{"period":"1year","weight":-0.0704},{"period":"ytd","weight":-0.0703}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"罗欣药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"41632人(较上一季度减少4.23%)","perCapita":"26083股","listingDate":"2016-04-15","address":"山东省临沂市罗庄区罗七路18号4号楼","registeredCapital":"108758万元","survey":" 罗欣药业集团股份有限公司的主营业务是药品制剂（含检测服务）及原料药的研发、生产和商业化。公司的主要产品是泰欣赞（替戈拉生片）。","listedPrice":11.97},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"罗欣药业(002793)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供罗欣药业(002793)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"罗欣药业,002793,罗欣药业股票,罗欣药业股票老虎,罗欣药业股票老虎国际,罗欣药业行情,罗欣药业股票行情,罗欣药业股价,罗欣药业股市,罗欣药业股票价格,罗欣药业股票交易,罗欣药业股票购买,罗欣药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"罗欣药业(002793)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供罗欣药业(002793)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}